Page 252 - MSU Digital Book
P. 252
Graft survival 4
Human leukocyte antigen 6, 123
Humoral immunity 5
Humoral rejection 5
Hyperacute rejection 5
Idiopathic membranoproliferative glomerulonephritis 64, 65, 72, 81, 127, 140
Idiopathic membranous nephropathy 64, 72, 75, 127
IgA nephropathy 64, 72, 73, 107
Immunosuppressant Therapy Adherence Scale 193
Immunosuppressive Adverse Effects Scoring System 187, 189, 191, 212, 213
Immunosuppressive Therapy Barriers Scale 196
Induction therapy 6, 12, 40, 48, 54, 81,
117, 168
Infection-related glomerulonephritis 64, 72, 87
Infusion-related reaction 146, 168
Initial therapy 71, 83, 86, 87, 88,
89, 175
Interleukin-2 receptor antibodies 8, 120, 125
Interstitial fibrosis 4, 6
Intravenous immunoglobulin 11, 89, 117, 135, 168
Kidney allograft biopsy 5
Kidney Disease Quality of Life-36 items 210
Kidney Disease Quality of Life-Short Form 210
Kidney Transplant Questionnaire 208
KTx360° 185, 186, 212, 213
Leflunomide 37, 38, 40, 74
Linear pharmacokinetics 32
Living donor 3
Loading dose 22, 133, 148, 177
Lupus nephritis 64, 72
Lymphocyte-depleting antibodies 8
227
